Mostrar el registro sencillo del ítem
Chronic obstructive pulmonary disease as a main factor of premature aging
| dc.creator | Karametos I., Tsiboli P., Togousidis I., Hatzoglou C., Giamouzis G., Gourgoulianis K.I. | en |
| dc.date.accessioned | 2023-01-31T08:31:13Z | |
| dc.date.available | 2023-01-31T08:31:13Z | |
| dc.date.issued | 2019 | |
| dc.identifier | 10.3390/ijerph16040540 | |
| dc.identifier.issn | 16617827 | |
| dc.identifier.uri | http://hdl.handle.net/11615/74400 | |
| dc.description.abstract | (1) Background: Chronic obstructive pulmonary disease (COPD) is defined as an inflammatory disorder that presents an increasingly prevalent health problem. Accelerated aging has been examined as a pathologic mechanism of many chronic diseases like COPD. We examined whether COPD is combined with accelerated aging, studying two hormones, dehydroepiandrosterone (DHEA) and growth hormone (GH), known to be characteristic biological markers of aging. (2) Methods: Data were collected from 119 participants, 70 (58.8%) COPD patients and 49 (41.2%) from a health control group over the period of 2014–2016 in a spirometry program. Information about their medical history, tobacco use, and blood tests was obtained. (3) Results: The average age of the health control patients was 73.5 years (SD = 5.5), and that of the COPD patients was 75.4 years (SD = 6.9). Both groups were similar in age and sex. A greater proportion of smokers were found in the COPD group (87.1%) versus the control group (36.7%). The majority of COPD patients were classified as STAGE II (51.4%) and STAGE III (37.1%) according to GOLD (Global Initiative for Chronic Obstructive Pulmonary Disease). Levels of DHEA (SD = 17.1) and GH (SD = 0.37) were significantly lower in the COPD group (p < 0.001) compared to those in the controls (SD = 26.3, SD = 0.79). DHEA and GH were more significant and negatively correlated with age. The regression equation of DHEA with age produced a coefficient equal to 1.26. In this study, the difference in DHEA between COPD patients and controls was, on average, 30.2 µg/dL, indicating that the biological age of a COPD patient is on average about 24 years older than that of a control subject of the same age. Similarly, the difference in GH between COPD patients and controls was, on average, 0.42 ng/mL, indicating that the biological age of a COPD patient is on average about 13.1 years older than that of a control subject of the same age. (4) Conclusions: The findings of our study strongly suggest the presence of premature biological aging in COPD patients. Their biological age could actually vary from 13 to 23 years older than non-COPD controls according to DHEA and GH variation. © 2019 by the authors. Licensee MDPI, Basel, Switzerland. | en |
| dc.language.iso | en | en |
| dc.source | International Journal of Environmental Research and Public Health | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061851405&doi=10.3390%2fijerph16040540&partnerID=40&md5=d8b4c05bcc858bd297d2bda3d6c2f890 | |
| dc.subject | biological marker | en |
| dc.subject | growth hormone | en |
| dc.subject | prasterone | en |
| dc.subject | prasterone sulfate | en |
| dc.subject | biological marker | en |
| dc.subject | growth hormone | en |
| dc.subject | prasterone | en |
| dc.subject | aging | en |
| dc.subject | biomarker | en |
| dc.subject | chronic obstructive pulmonary disease | en |
| dc.subject | hormone | en |
| dc.subject | pathology | en |
| dc.subject | regression analysis | en |
| dc.subject | acceleration | en |
| dc.subject | adult | en |
| dc.subject | age | en |
| dc.subject | aged | en |
| dc.subject | aging | en |
| dc.subject | Article | en |
| dc.subject | biological activity | en |
| dc.subject | biological variation | en |
| dc.subject | blood analysis | en |
| dc.subject | chronic obstructive lung disease | en |
| dc.subject | controlled study | en |
| dc.subject | cross-sectional study | en |
| dc.subject | disease classification | en |
| dc.subject | female | en |
| dc.subject | hormone determination | en |
| dc.subject | human | en |
| dc.subject | information processing | en |
| dc.subject | major clinical study | en |
| dc.subject | male | en |
| dc.subject | medical history | en |
| dc.subject | middle aged | en |
| dc.subject | premature aging | en |
| dc.subject | risk factor | en |
| dc.subject | sex difference | en |
| dc.subject | smoking | en |
| dc.subject | spirometry | en |
| dc.subject | tobacco use | en |
| dc.subject | blood | en |
| dc.subject | chronic obstructive lung disease | en |
| dc.subject | complication | en |
| dc.subject | metabolism | en |
| dc.subject | pathophysiology | en |
| dc.subject | premature aging | en |
| dc.subject | prevalence | en |
| dc.subject | risk factor | en |
| dc.subject | very elderly | en |
| dc.subject | Nicotiana tabacum | en |
| dc.subject | Aged | en |
| dc.subject | Aged, 80 and over | en |
| dc.subject | Aging, Premature | en |
| dc.subject | Biomarkers | en |
| dc.subject | Dehydroepiandrosterone | en |
| dc.subject | Female | en |
| dc.subject | Growth Hormone | en |
| dc.subject | Humans | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Prevalence | en |
| dc.subject | Pulmonary Disease, Chronic Obstructive | en |
| dc.subject | Risk Factors | en |
| dc.subject | Smoking | en |
| dc.subject | Spirometry | en |
| dc.subject | MDPI AG | en |
| dc.title | Chronic obstructive pulmonary disease as a main factor of premature aging | en |
| dc.type | journalArticle | en |
Ficheros en el ítem
| Ficheros | Tamaño | Formato | Ver |
|---|---|---|---|
|
No hay ficheros asociados a este ítem. |
|||